"10.1371_journal.pone.0084866","plos one","2014-01-22T00:00:00Z","Nguyen Thi Ngoc Lan; Nguyen Thi Nguyet Thu; Aurélie Barrail-Tran; Nguyen Hong Duc; Nguyen Ngoc Lan; Didier Laureillard; Truong Thi Xuan Lien; Laurence Borand; Catherine Quillet; Catherine Connolly; Dominique Lagarde; Alexander Pym; Christian Lienhardt; Nguyen Huy Dung; Anne-Marie Taburet; Anthony D Harries","Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam; Pasteur Institute, Ho Chi Minh City, Vietnam; Clinical Pharmacy Department, Bicêtre Hospital, Assistance-Publique Hôpitaux de Paris, Kremlin-Bicêtre, France; ANRS, Ho Chi Minh City, Vietnam; Epidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia; Biostatistics Unit, Medical Research Council, Durban, South Africa; The International Union Against Tuberculosis and Lung Diseases, Paris, France; TB Research Unit, Medical Research Council, Durban, South Africa; KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), South Africa; World Health Organization Stop Tuberculosis Program, Geneva, Switzerland; Clinical Pharmacy and Pharmacokinetics Department (EA4123), University Paris Sud, Chatenay Malabry, France; London School of Hygiene and Tropical Medicine, London, United Kingdom","Conceived and designed the experiments: NTNL D. Laureillard D. Lagarde AP CL ADH. Performed the experiments: NTNL NTNT ABT NHD NNL TTXL NHD. Analyzed the data: NTNT ABT AMT D. Laureillard LB CQ CC D. Lagarde. Wrote the paper: NTNL NTNT ABT NHD NNL D. Laureillard TTXL LB CQ CC D. Lagarde AP CL NHD AMT ADH. Wrote the first draft of the manuscript: AMT D. Lagarde ADH. ICMJE criteria for authorship read and met: NTNL NTNT ABT NHD NNL D. Laureillard TTXL LB CQ CC  D. Lagarde AP CL NHD AMT ADH. Agree with manuscript results and conclusions: NTNL NTNT ABT NHD NNL D. Laureillard TTXL LB CQ CC  D. Lagarde AP CL NHD AMT ADH.","The authors declare that the French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Institut national de la santé et de la recherche médicale-Agence Nationale de Recherche sur le Sida) was the Sponsor and Funder of the study. Fondation Total also provided a grant to support the study. The authors also declare that they received a donation of rifabutin from Laboratoires SERB and a donation of rifabutin and 25-O-desacetyl rifabutin reference powder from Pfizer (SA) which was used for the preparation of standard curves and quality control of assays. The French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (INSERM-ANRS), Fondation Total, Laboratoires SERB and Pfizer (SA) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore, receipt of the donations from Laboratoires SERB and Pfizer (SA) does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Nguyen Thi Ngoc Lan","NTNL",16,TRUE,2,6,4,6,TRUE,FALSE,TRUE,5,"8;9;10;12;13",TRUE
